Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design and Validation of an Augmented Hematopoietic Cell Transplantation-Comorbidity Index Comprising Pretransplant Ferritin, Albumin, and Platelet Count for Prediction of Outcomes after Allogeneic Transplantation.
Vaughn JE, Storer BE, Armand P, Raimondi R, Gibson C, Rambaldi A, Ciceri F, Oneto R, Bruno B, Martin PJ, Sandmaier BM, Storb R, Sorror ML. Vaughn JE, et al. Among authors: storer be. Biol Blood Marrow Transplant. 2015 Aug;21(8):1418-24. doi: 10.1016/j.bbmt.2015.04.002. Epub 2015 Apr 7. Biol Blood Marrow Transplant. 2015. PMID: 25862589 Free PMC article.
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia.
Baron F, Maris MB, Storer BE, Sandmaier BM, Stuart MJ, McSweeney PA, Radich JP, Pulsipher MA, Agura ED, Chauncey TR, Maloney DG, Shizuru JA, Storb R. Baron F, et al. Among authors: storer be. Biol Blood Marrow Transplant. 2005 Apr;11(4):272-9. doi: 10.1016/j.bbmt.2004.12.326. Biol Blood Marrow Transplant. 2005. PMID: 15812392 Free article.
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.
Maris MB, Sandmaier BM, Storer BE, Maloney DG, Shizuru JA, Agura E, Kliem C, Pulsipher M, Maziarz RT, McSweeney PA, Wade J, Langston AA, Chauncey TR, Bruno B, Blume KG, Storb R. Maris MB, et al. Among authors: storer be. Biol Blood Marrow Transplant. 2006 Apr;12(4):454-65. doi: 10.1016/j.bbmt.2005.12.030. Biol Blood Marrow Transplant. 2006. PMID: 16545729 Free article. Clinical Trial.
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.
Deeg HJ, Storer BE, Boeckh M, Martin PJ, McCune JS, Myerson D, Heimfeld S, Flowers ME, Anasetti C, Doney KC, Hansen JA, Kiem HP, Nash RA, O'Donnell PV, Radich JP, Sandmaier BM, Scott BL, Sorror ML, Warren EH, Witherspoon RP, Woolfrey A, Appelbaum FR, Storb R. Deeg HJ, et al. Among authors: storer be. Biol Blood Marrow Transplant. 2006 May;12(5):573-84. doi: 10.1016/j.bbmt.2005.12.036. Biol Blood Marrow Transplant. 2006. PMID: 16635793 Free article. Clinical Trial.
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
Baron F, Storb R, Storer BE, Maris MB, Niederwieser D, Shizuru JA, Chauncey TR, Bruno B, Forman SJ, McSweeney PA, Maziarz RT, Pulsipher MA, Agura ED, Wade J, Sorror M, Maloney DG, Sandmaier BM. Baron F, et al. Among authors: storer be. J Clin Oncol. 2006 Sep 1;24(25):4150-7. doi: 10.1200/JCO.2006.06.9914. Epub 2006 Aug 8. J Clin Oncol. 2006. PMID: 16896000
Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.
Georges GE, Maris MB, Maloney DG, Sandmaier BM, Sorror ML, Shizuru JA, Lange T, Agura ED, Bruno B, McSweeney PA, Pulsipher MA, Chauncey TR, Mielcarek M, Storer BE, Storb R. Georges GE, et al. Among authors: storer be. Biol Blood Marrow Transplant. 2007 Apr;13(4):423-32. doi: 10.1016/j.bbmt.2006.11.011. Epub 2007 Feb 1. Biol Blood Marrow Transplant. 2007. PMID: 17287157 Free PMC article. Clinical Trial.
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Kahl C, Storer BE, Sandmaier BM, Mielcarek M, Maris MB, Blume KG, Niederwieser D, Chauncey TR, Forman SJ, Agura E, Leis JF, Bruno B, Langston A, Pulsipher MA, McSweeney PA, Wade JC, Epner E, Bo Petersen F, Bethge WA, Maloney DG, Storb R. Kahl C, et al. Among authors: storer be. Blood. 2007 Oct 1;110(7):2744-8. doi: 10.1182/blood-2007-03-078592. Epub 2007 Jun 26. Blood. 2007. PMID: 17595333 Free PMC article.
Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.
Sorror ML, Sandmaier BM, Storer BE, Maris MB, Baron F, Maloney DG, Scott BL, Deeg HJ, Appelbaum FR, Storb R. Sorror ML, et al. Among authors: storer be. J Clin Oncol. 2007 Sep 20;25(27):4246-54. doi: 10.1200/JCO.2006.09.7865. Epub 2007 Aug 27. J Clin Oncol. 2007. PMID: 17724349
404 results